EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The prognostic value of albumin-corrected anion gap for major adverse cardiac events in chronic kidney disease patients undergoing percutaneous coronary intervention

Ziqiang Guo, Xue Zhang, Yahui Lu, Kangyin Chen

Frontiers in Cardiovascular Medicine · 27.03.2026 · 13

DOI: 10.3389/fcvm.2026.1675923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 27.03.2026. Verfasst von Ziqiang Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiovascular disease currently holds the highest morbidity and mortality rates globally. The survival of patients with coronary artery disease (CAD) complicated by chronic kidney disease (CKD) remains a significant threat, posing challenges in management and timely treatment. This study aims to explore the relationship between the Albumin-Corrected Anion Gap (ACAG) and the prognosis of patients with CKD Receiving Percutaneous Coronary Intervention.

Methods

This was a single-center, retrospective study including 973 patients who underwent percutaneous coronary intervention (PCI) at Tianjin Medical University Second Hospital from January 2019 to June 2023, all with an estimated glomerular filtration rate (eGFR) of less than or equal to 60 mL/min/1.73 m 2 . Follow-up was completed in June 2023. The primary efficacy endpoint was the time-to-first occurrence of major adverse cardiovascular events (MACE), defined as the composite of cardiovascular death, recurrent myocardial infarction (MI), or non-fatal stroke. The key secondary endpoint was all-cause mortality, Additional secondary endpoints included (1) the individual components of the primary composite, (2) recurrent MACE (i.e., events after the first occurrence), and (3) any repeat revascularization.

Results

After a follow-up of 918.0 ± 364.7 days, 205 MACEs were recorded. Receiver Operating Characteristic (ROC) curve analysis identified the optimal cutoff value for trial subjects. Compared to the low-ACAG group, the high-ACAG group exhibited a higher incidence of MACEs (29.65% vs. 15.78%, P < 0.001) and all-cause mortality (29.92% vs. 11.96%, P < 0.001). The Kaplan–Meier survival curve indicated that the low-ACAG group had a higher survival rate. Restricted cubic spline (RCS) analysis suggested that ACAG was positively correlated with MACE events. Univariate and multivariate Cox regression analysis indicated that a high ACAG level (HR: 1.820;95%CI: 1.300–2.546, P < 0.001) and the use of diuretics during hospitalization (HR: 1.653;95%CI: 1.195–2.286, P = 0.002) were independently associated with the occurrence of MACEs in patients with CAD and CKD. After adding ACAG and eGFR to the traditional risk model, Decision Curve Analysis (DCA) pointed out that DCA could improve the clinical net benefit within a certain range.

Conclusions

Among patients undergoing PCI treatment for chronic kidney disease, elevated ACAG levels are closely related to the patient's cardiac mortality and all-cause mortality rates. Additionally, the use of diuretics in patients with CAD and CKD requires caution and should optimize treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

acidosis and oxidative stressalbumin-corrected anion gap (ACAG)chronic kidney diseasecoronary artery diseasepercutaneous coronary intervention

Autor:innen und Institutionen

  • Department of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.
  • Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China.

Zitieren

APA

Guo, Z., Zhang, X., Lu, Y., & Chen, K. (2026). The prognostic value of albumin-corrected anion gap for major adverse cardiac events in chronic kidney disease patients undergoing percutaneous coronary intervention. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1675923

Vancouver

Guo Z, Zhang X, Lu Y, Chen K. The prognostic value of albumin-corrected anion gap for major adverse cardiac events in chronic kidney disease patients undergoing percutaneous coronary intervention. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1675923

BibTeX
@article{Guo2026,
  author = {Guo, Ziqiang and Zhang, Xue and Lu, Yahui and Chen, Kangyin},
  title = {The prognostic value of albumin-corrected anion gap for major adverse cardiac events in chronic kidney disease patients undergoing percutaneous coronary intervention},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1675923}
}
Kostenlos starten →